7.030USD+0.14%Mkt Cap: 199.81M USDP/E: —Last update: 2026-05-22
Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA techno…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap199.81M USD
Enterprise Value12.14M USD
Revenue (TTM)54.71M USD
Gross Profit-44.14M USD
Net Income (TTM)-65.78M USD
Revenue/Share1.974 USD
Last Price7.030 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees106
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.76
PEG—
EV/EBITDA-0.14
EV/Revenue0.22
P/S3.65
P/B1.04
EPS (TTM)-2.83
EPS (Forward)-3.99
52W Range
5.8506% of range24.17
52W High24.17 USD
52W Low5.850 USD
Profitability
Gross Margin-80.67%
Oper. Margin-1403.74%
EBITDA Margin-156.25%
Profit Margin-97.86%
ROE-30.74%
ROA-24.26%
Growth
Revenue Growth-93.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-74.27M USD
CapEx (TTM)230.00K USD
FCF Margin20.63%
FCF Yield5.65%
Net Debt-187.39M USD
Net Debt/EBITDA2.19
Balance Sheet
Debt/Equity0.12
Current Ratio6.31
Quick Ratio6.19
Book Value/Sh6.733 USD
Cash/Share7.437 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 16, 2017
Splits
Last Split1:7
Split DateNov 16, 2017
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)19.89 USD
Target Range8.000 USD – 40.00 USD
# Analysts9
Ownership
Shares Out.28.42M
Float26.15M
Insiders7.99%
Institutions79.71%
Short Interest
Short Ratio15.5d
Short % Float28.19%
Short % Out.22.66%
Shares Short6.44M
Short (prev mo.)6.45M
Technical
SMA 507.905 (-11.1%)
SMA 20010.62 (-33.8%)
Beta2.42
S&P 52W Chg28.31%
Avg Vol (30d)408.40K
Avg Vol (10d)553.91K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—